The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria.
Conclusion: Patients in the intermediate-risk group had different prognoses depending on the number of positive risk factors.
PMID: 29963234 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Calcium | Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Pancreas | Pancreatic Cancer | Renal Cell Carcinoma